期刊文献+

晚期喉癌切缘组织流式细胞仪参数及PCNA表达的研究 被引量:3

Changes of flow cytometry parameters and PCNA expression in the adjacent tissues of advanced laryngeal carcinoma
下载PDF
导出
摘要 目的:探索细胞增殖活性在晚期喉癌组织周围的变化规律,确定合理的晚期喉癌安全切缘。方法:用流式细胞仪及免疫组化检测晚期喉癌患者喉癌组织(A组)、癌旁0.5cm(B组)、1.0cm(C组)、2.0cm(D组)处组织细胞的DNA异质性、DNA含量、增殖指数及PCNA表达。结果:异倍体率:喉癌组织、0.5cm、1.0cm、2.0cm处组织分别为70.4%、14.8%、0、0。A与B组和B与C组间均有显著性差异;DI值:A、B、C对组分别为1.61±0.52、1.08±0.38、1.03±0.31、1.02±0.13,A与B组和B与C组间均有显著性差异;PI值(%)分别为26.06±6.73、12.27±3.78、11.37±2.86、11.01±1.92从组与B组间有显著性差异,但B组与C组、C组与D组间均无显著性差异;SPF值(%)分别为22.38±6.15、11.17±3.92、10.81±3.37、10.55±3.06,免疫组化PCNA指数(%)分别为67.8±12.25、12.76±4.36、11.33±3.25、10.89±3.13。结论:从晚期喉癌组织向周围正常组织移动过程中,肿瘤细胞的增殖指标、DNA含量逐渐趋向正常,于癌周0.5cm处接近正常,于1.0cm处基本正常;晚期喉癌旁0.5cm可作为手术的基本安全切缘,1.0cm可作为理想安全切缘。 Objective: To study how cellular proliferative vigor and PCNA expression change between advanced laryngeal carcinoma (LC) and the adjacent tissues of cancer, and to determine the safe surgical margin of larynx with advanced LC. Methods: The specimens acquired from LC tissue and the tissues at the sites of 0. 5cm, 1.0cm, 2.0cm away from LC periphery were classified as four groups A,B,C,D, and were detected by approaches of flow cytometry and immunohisto-chemistry. Results: Heteroploid rates of tissues in A,B,C,D groups were 70. 4% , 14. 8% ,0,0 respectively. The difference between A and B groups, B and C groups were significant. DI in groups A,B,C, and D were 1. 61 ±0. 52, 1. 08±0. 38,1. 03±0. 31,1. 02±0. 13 respectively, the differences between A and B, B and C were significant, and the difference between C and D is not significant. PI (%) were 26. 06±6. 73,12. 27±3. 78,11. 37±2. 86,11. 01±1. 92 respectively, the difference between A and B was significant and differences between B and C, C and D were not significant. SPF (%) were 22. 38 ±6. 15,11. 17±3. 92,10. 81±3. 37,10. 55±3. 06 respectively. The results of statistical analysis were similar to PI. PCNA index (%) was 67. 8±12. 25, 12. 76±4. 36,11. 33±3.25,10. 89±3. 13 respectively. The results of statistical analysis were similar to DI. Conclusions: The parameters including heteroploid, DNA content, proliferative index, PCNA, etc, turned gradually into normal level from LC tissues to the normal tissue. These results are near to normal level in the tissues at the site of 0.5cm away from LC, and are normal at 1. 0cm away from LC. 0. 5cm away from LC periphery may be determined as basic safe surgical margin, and 1.0cm may be determined satisfactory safe surgical margin.
出处 《耳鼻咽喉(头颈外科)》 2003年第3期163-167,共5页 Chinese Arch Otolaryngology-Head Neck Surg
关键词 晚期癌症 喉癌 切缘组织 流式细胞仪 PCNA 免疫组化法 细胞增殖 (Larynx Neoplasms) (Flow Cytometry) (Proliferating Cell Nu-clear Antigen)
  • 相关文献

参考文献9

  • 1[1]Nicolson GI. Tumor cell instability, diversification and progression. Cancer Res. 1978 ; 47:1473- 1480.
  • 2[2]Rarlogie B. Cellular DNA content as a marker of neoplasia in human. Am J Med. 1980;69:195-201.
  • 3[3]Johnson TS. Flow cytometry analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded section: comparison with maliguancy grading. Cytometry.1985;6:461-465.
  • 4[4]Auer G. Prognostic significance of nuclear DNA content in mammary adenocarcinoma in human. Cancer Res. 1984;44:394-398.
  • 5[6]Truelson JM, Fisners G, Beals TE, et al. DNA content and histologic growth pattern correlate with prognosis in patients with advanced squamous cell carcinoma of larynx.Cancer. 1992;70:56-62.
  • 6[7]Shou W, Gregory GH, David B, et al. The p21 inhibitor of cyclin-dependent kinases control DNA replication by interaction with PCNA. Nature. 1994;369:574-578.
  • 7[8]Dierendonck JH, Wijsman JH, Keijzer K, et al. Cell-cyclerelated staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies, comparison with BrdUrd labeling and ki-67 staining. Am J Pathol. 1991;138:1165-1172.
  • 8[12]Lam KH, Lau WF, Wei WI. Tumor clearance at resection margins in total laryngectomy. A clinicopatholoic study. Cancer. 1988;61:2260-2272.
  • 9[13]Vikram B, Strong EW, Shan ZT,et al. Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg. 1986; 6: 720-726.

同被引文献33

  • 1温树信,唐平章,徐震纲,祁永发,张宗敏,刘明波,边学,王建宏.声门下型喉癌的外科治疗[J].中华耳鼻咽喉头颈外科杂志,2005,40(6):419-422. 被引量:6
  • 2武乃旺,刘建伟,康秀水.双蒂双肌瓣喉功能重建法[J].中华耳鼻咽喉科杂志,1996,31(3):178-180. 被引量:31
  • 3温晓霞,季文樾,关超.声门上喉癌大体形态与生物学特性的关系研究[J].实用医学杂志,2006,22(6):648-649. 被引量:3
  • 4费声重 时曜唏 王尔莉 等.278例喉部分切除术生存分析[J].中华耳鼻咽喉科杂志,1986,21(5):281-283.
  • 5罗力生,高建华.陈林峰.等.股前外侧皮瓣及其游离移植的应用[J].第一军医大学学报,1984,4(4):1-5.
  • 6WEI F C, JAIN V, CELIK N, et al. Have we foundan ideal soft-tissue flap. An experience with 672 an-terolateral thigh flaps [J]. Plast Reconstr Surg,2002,109: 2219-2230.
  • 7YILDIRIM S, AVCI G,AKOZ T. Soft-tissue recon-struction using a free anterolateral thigh flap: experi-ence with 28 patients[J], Ann Plast Surg, 2003,51 :37-44.
  • 8SONG Y G,CHEN G Z, SONG Y L. The free thighflap: a new free flap concept based on the septocuta-neous artery[J]. Br J Plast Surg,1984,37:149_159.
  • 9KOSHIMA I,FUKUDA H,YAMAMOTO H, etal. Free anterolateral thigh flaps for reconstruction ofhead and neck defects[J], Plast Reconstr Surg,1993,92: 421-430.
  • 10GEDEBOU T M,WEI FC, LIN C H. Clinical expe-rience of 1284 free anterolateral thigh flaps [J].Handchir Mikrochir Plast Chir, 2002,34:239 - 244.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部